Current stock page

Catalysts

NTRA Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Diagnostics & ResearchScore data as of Oct 21, 2026

NTRANatera, Inc.

Healthcare / Medical - Diagnostics & Research

Low Priority

In Line With Peers

NeutralEdge 4/10
$413.38+$7.46 (+1.84%)

Latest quote

  • Momentum
    55
  • Value
    34
  • Quality
    57
  • Risk resilience
    57
  • Sentiment
    75
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 5, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 50/100

Momentum 55/100 and sentiment 75/100 before the next covered event.

Recent coverage
4 articles

Updated Oct 21, 2026 · Sentiment 30.58%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 55/100AIQ Edge 4/10 In Line With Peers
Beat rate
43%
3 of 7 reported periods
Average surprise
+14.0%
Across covered historical reports
Latest result
+4.8%
Aug 6, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 5, 2026—-$0.22——$707.87M—
Aug 6, 2026—-$0.49-$0.47+4.8%$661.24M$752.75M
May 7, 2026—-$0.54-$0.56-3.3%$617.1M$696.64M
Feb 26, 2026—-$0.51$0.35+168.4%$604.04M$665.5M
Nov 6, 2025—-$0.39-$0.64-65.9%$513.45M$592.18M
Aug 7, 2025—-$0.62-$0.74-20.2%$476.26M$546.6M
May 8, 2025—-$0.64-$0.50+21.9%$446.23M$501.83M
Feb 27, 2025—-$0.38-$0.41-7.6%$435.64M$476.06M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
21
Buy
2
Hold
12-month analyst target
$332.28
-19.62% versus current price
Based on 15 analyst observations. Targets are estimates, not predictions.
Low target
$220.00
-46.78% vs latest price
Average target
$332.28
-19.62% vs latest price
High target
$475.00
+14.91% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 5, 2026

Next known earnings or reporting date.

EPS estimate-$0.27

Current analyst expectation for the upcoming report.

Revenue estimate$707.67M

Current analyst expectation for the upcoming report.

Sentiment score75

News pressure around the setup.

Momentum score55

Where event reaction would show up first.

AIQ score50/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
15
Average target
$332.28
Target upside
-19.62%
Target range
$220.00 - $475.00
90-day revisions
-5

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
insidermonkey.com · Oct 20, 2026

Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?

Testing Volume Is Growing Faster Than the Valuation Can Ignore Natera, Inc.

gurufocus.com · Oct 19, 2026

NTRA Maintained by Canaccord Genuity -- Price Target Raised to $500

Natera Inc (NTRA) Analyst Rating Update On October 16, 2026, Natera (NTRA) received a maintained Buy rating from Canaccord Genuity, with the price target inc

gurufocus.com · Oct 19, 2026

Natera (NTRA) to Present 20 Abstracts Showcasing Advanced MRD Technology at ESMO 2026

On October 18, 2026, Natera Inc (NASDAQ: NTRA) announced it will present 20 abstracts at the upcoming 2026 European Society for Medical Oncology (ESMO) Annual C

gurufocus.com · Oct 14, 2026

NTRA Maintained by JP Morgan -- Price Target Raised to $460

On October 13, 2026, JP Morgan maintained an Overweight rating on Natera Inc (NTRA), with analyst Casey Woodring announcing an increase in the price target from

Open full news and sentiment

NTRA Catalysts FAQ

What are the next catalysts for NTRA stock?

NTRA's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move NTRA stock?

Upcoming events that could move NTRA include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could NTRA's next earnings report affect the stock?

NTRA's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive NTRA stock higher?

NTRA could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt NTRA stock?

NTRA could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.